Huimin Wang

机构：Zhejiang University of Science and Technology, Shanghai Jiao Tong University, Shanghai Chest Hospital, Wuhan Third Hospital, Shanghai First Maternity and Infant Hospital · ORCID：0000-0001-8468-2974

发表论文 84 篇 · 总被引 1675 次 · h-index 22

代表论文

• Paclitaxel Has a Reduced Toxicity Profile in Healthy Rats After Polymeric Micellar Nanoparticle Delivery (2023 · International Journal of Nanomedicine · 被引 13)
• Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancer (2025 · Signal Transduction and Targeted Therapy · 被引 12)
• Blood-based tumour mutation index act as prognostic predictor for immunotherapy and chemotherapy in non-small cell lung cancer patients (2022 · Biomarker Research · 被引 12)
• Screening anlotinib responders via blood‐based proteomics in non‐small cell lung cancer (2022 · The FASEB Journal · 被引 9)
• Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm, two-stage study (2024 · BMC Cancer · 被引 8)
• Rapid hydroclimate fluctuation in eastern China coastal plain restrain Neolithic cultures development: A mineral magnetic study (2023 · CATENA · 被引 8)